Skip to main content
TFF Pharmaceuticals, Inc. (TFFP)
NASDAQ: TFFP · IEX Real-Time Price · USD
3.350
+0.210 (6.69%)
At close: Apr 19, 2024, 11:40 AM
3.290
-0.060 (-1.79%)
After-hours: Apr 19, 2024, 4:44 PM EDT

TFF Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Revenue
0.730.50.090000
Revenue Growth (YoY)
48.02%462.39%-----
Gross Profit
0.730.50.090000
Selling, General & Admin
10.5713.810.578.013.173.050.18
Research & Development
12.0618.521.310.688.820.850
Operating Expenses
22.6332.2931.8718.6911.993.90.18
Operating Income
-21.89-31.8-31.79-18.69-11.99-3.9-0.18
Other Expense / Income
-0.65-0.03-0.75-0.13-0.12-0.06-
Pretax Income
-21.24-31.77-31.04-18.57-11.87-3.84-0.18
Net Income
-21.24-31.77-31.04-18.57-11.87-3.84-0.18
Preferred Dividends
000024.810.730
Net Income Common
-21.24-31.77-31.04-18.57-36.68-4.57-0.18
Shares Outstanding (Basic)
211100-
Shares Outstanding (Diluted)
211100-
Shares Change
49.48%20.78%21.52%195.80%98.20%--
EPS (Basic)
-11.85-26.49-31.25-22.75-132.75-32.75-
EPS (Diluted)
-11.85-26.49-31.25-22.75-132.75-32.75-
Free Cash Flow
-16.13-28.89-30.43-17.72-11.22-2.13-0.19
Free Cash Flow Per Share
-9.00-24.09-30.64-21.69-40.61-15.26-
Gross Margin
100.00%100.00%100.00%----
Operating Margin
-2983.45%-6413.16%-36055.24%----
Profit Margin
-2894.68%-6407.77%-35206.85%----
Free Cash Flow Margin
-2198.34%-5827.59%-34511.26%----
EBITDA
-20.74-31.38-30.93-18.57-11.87-3.84-0.18
EBITDA Margin
-2826.21%-6329.47%-35080.43%----
Depreciation & Amortization
0.50.390.110000
EBIT
-21.24-31.77-31.04-18.57-11.87-3.84-0.18
EBIT Margin
-2894.68%-6407.77%-35206.85%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).